Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN25455020
ISRCTN25455020
Completed
Not Applicable

Cognitive behavioural treatment of negative symptoms in patients with schizophrenic disorders

niversity Hospital Tuebingen (Germany)0 sites198 target enrollmentNovember 21, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSchizophreniaMental and Behavioural Disorders

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
niversity Hospital Tuebingen (Germany)
Enrollment
198
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 21, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity Hospital Tuebingen (Germany)

Eligibility Criteria

Inclusion Criteria

  • •1\. Schizophrenia (Diagnostic and Statistical Manual of Mental Disorders \- fourth edition \[DSM\-IV] 295\.1, 295\.2, 295\.3, 295\.4, 295\.6, 295\.9\)
  • •2\. PANSS Modified Negative Syndrome Score \=10
  • •3\. Fluency of German language

Exclusion Criteria

  • •1\. Severe positive symptoms (any item of the standard PANSS positive scale \[P1, P2, P3, P4, P5, P6, P7] \=6\)
  • •2\. Severe depression as indicated by PANSS G6 \=6
  • •3\. Extrapyramidal symptoms
  • •4\. Age below 18 or over 55
  • •5\. Organic disorder interfering with the central nervous system
  • •6\. Verbal IQ \<80
  • •7\. Diagnosis of substance abuse or substance dependence according to DSM\-IV/Structured Clinical Interview for Depression (SCID\-I) as primary clinical problem
  • •8\. Travel time to the study centre of more than 1 hour

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Cognitive behavioural therapy for the treatment of late life depression – a multicentre, randomized, observer- blinded, controlled trial (CBTlate)F33Depressive episodeF32Recurrent depressive disorder
DRKS00013769niversitätsklinikum Köln Klinik für Psychiatrie und Psychotherapie248
Recruiting
Not Applicable
A cognitive-behavioural approach for the treatment of fear of progression in patients wth Parkinson's disease and Multiple Sclerosis: A Mixed-Methods StudyFear of ProgressionG20G35Parkinson diseaseMultiple sclerosis
DRKS00020989Medizinische Psychologie | Neuropsychologie und Gender StudiesCentrum für Neuropsychologische Diagnostik und Intervention (CeNDI), Medizinische Fakultät und Uniklinik Köln, Universität zu Köln147
Completed
Not Applicable
A brief cognitive behavioural intervention for people with methamphetamine use problemsmethamphetamine usedepressionMental Health - AddictionMental Health - Depression
ACTRN12611000355976niversity of Newcastle214
Completed
Not Applicable
The evaluation and treatment of cognitive symptoms in patients with multiple sclerosis (MS)Multiple sclerosis (MS)Nervous System DiseasesMultiple sclerosis
ISRCTN53885363Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)36
Active, not recruiting
Not Applicable
Therapy for the treatment of children with inattention and hyperactivityAttention Deficit Disorder with HyperactivityF03.550.150.150
RBR-9fqwywniversidade Federal de São Paulo